Another Onglyza case filed

Friday, Dec 8, 2017
  • Onglyza Medical Record Review & Outsourcing Services

A product liability lawsuit was filed against Bristol-Myers Squibb and AstraZeneca by a woman who suffered heart failure and other severe cardiovascular complications alleging to be side effects of the saxagliptin-based diabetes drugs, Onglyza and Kombiglyze XR. The complaint was filed in the U.S. District Court for the Northern District of Alabama in early December. The lawsuits state that the defendants had knowledge that there was a significantly increased risk of adverse events associated with Saxagliptin, despite this they continued to manufacture, market, distribute, sell, and profit from the sales of Saxagliptin. A request for consolidating Onglyza lawsuits was made recently. The U.S. JPML is expected to consider oral arguments on the motion during an upcoming hearing in January 2018.

We are social:

Accreditations

HIPAA

Neural IT has successfully implemented HIPAA for securing Health records....

ISO 27001 Certification

Neural IT has successfully passed the ISMS re-certification audit and is now ISO 27001:2013 certi...

NSIC - CRISIL

NSIC-CRISIL has assigned a "SE 2A" rating to Neural IT, indicating a company with High Performanc...

Associations

CAALA

CAALA - "Neural IT is proud to be associated with CAALA (Consumer Attorneys Association of Los An...

CAOC

CAOC - "Neural IT is proud to be associated with CAOC (Consumer Attorneys of California) as a Ven...

NYSTLA

NYSTLA - "Neural IT is proud to be associated with NYSTLA (New York State Trial Lawyers Associati...

News & Events

MTMP April 2019
Neural IT shared presence with Mike Papantonio at the spectacular 3-day conferenc
1st Quarter 2019 ‘Rewards & Recognition Program
Neural IT celebrated Employee Appreciation Day on April 5, 2019, by rewarding its star performers
Best HRMS Vendor 2019
The Neural IT team was felicitated with the 'Best HRMS Vendor 2019' award for

Latest Tweets